🇺🇸 FDA
Pipeline program

SOF/VEL/VOX

GS-US-367-1909

Phase 1 small_molecule completed

Quick answer

SOF/VEL/VOX for HCV Infection is a Phase 1 program (small_molecule) at Gilead Sciences Ireland UC with 1 ClinicalTrials.gov record(s).

Program details

Company
Gilead Sciences Ireland UC
Indication
HCV Infection
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials